Source
5 developments in the corpus
Latest
Everything in the corpus, newest first.
NOV 2, 2026 · JOURNAL ARTICLE
International Journal of Cancer
ABSTRACT Medication taken for other reasons than for the treatment of malignant disease, termed concomitant medication, is known to affect outcomes when used with immune checkpoint
OCT 20, 2026 · JOURNAL ARTICLE
International Journal of Cancer
ABSTRACT Immune checkpoint inhibitors such as anti–PD‐1 antibodies are essential in cancer therapy. Emerging data suggest that lower doses may be effective and more economical, tho
OCT 14, 2026 · JOURNAL ARTICLE
International Journal of Cancer
ABSTRACT Neoadjuvant therapy has recently become an integral component of multimodal treatment for resectable lung cancer. However, real‐world data on perioperative morbidity and t
OCT 9, 2026 · JOURNAL ARTICLE
International Journal of Cancer
ABSTRACT Cancer survivors face elevated risks of age‐ and treatment‐related health conditions, possibly due to accelerated biological aging from cancer therapy. The role of social
SEP 15, 2026 · JOURNAL ARTICLE
International Journal of Cancer
Human papillomavirus (HPV) is the necessary cause of cervical cancer and responsible for ~90% of anal, 78% of vaginal, 50% of penile, and 25% of vulvar cancers. In Costa Rica (CR),